Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The dentin collagen-mineral interface is a specialized structural zone within the tooth where the organic extracellular matrix, primarily composed of Type I collagen, integrates with the inorganic mineral phase of hydroxyapatite (StatPearls, "Anatomy, Head and Neck, Tooth"). This interface is fundamental to the tooth's mechanical resilience and serves as the substrate for modern adhesive dentistry, forming what is known as the "hybrid layer" during restorative procedures (PubMed, PMID: 18241436). In pathological states such as dental caries, bacterial acids demineralize the hydroxyapatite, exposing the collagen scaffold to degradation by endogenous enzymes like matrix metalloproteinases (MMPs) and cysteine cathepsins (PubMed, PMID: 15126527). Therapeutic interventions target this interface to arrest decay and improve the longevity of dental fillings; for instance, MMP inhibitors like chlorhexidine are used to prevent collagen breakdown, while fluoride and bioactive materials promote remineralization (PubMed, PMID: 23403544). Furthermore, the exposure of this interface due to enamel loss or gingival recession is a primary cause of dentin hypersensitivity, as it allows external stimuli to reach the pulp via dentinal tubules. Consequently, this interface is a critical focus for both preventive and restorative dental medicine. Understanding the biochemical and mechanical properties of this interface is essential for developing long-lasting dental materials and regenerative therapies.
The mechanism of action involves the chemical bonding of functional monomers to hydroxyapatite, the inhibition of host-derived proteolytic enzymes (MMPs) to preserve the collagen matrix, and the promotion of epitaxial mineral growth to restore the inorganic-organic balance (PubMed, PMID: 21159144).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dentin collagen-mineral interface.